Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 6 consecutive quarters of double digit growth.
Click here to learn more ›
Treatment Satisfaction With Subcutaneous Bremelanotide Self-administered at Home by Premenopausal Women With Female Sexual Dysfunction: A Placebo-controlled Dose-ranging Study
